New York State Common Retirement Fund’s Elicio Therapeutics ELTX Stock Holding History

New York State Common Retirement Fund’s Portfolio ELTX Stock Details ELTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.5K	Buy	+14,200	New	+$143K	﹤0.01%	2967
2022 Q3	–	Sell	-19	Closed	–	–	3323
2022 Q2	$0	Sell	19 -570	-97%	-$9.1K	﹤0.01%	3489
2022 Q1	$12K	Sell	589 -4	-0.7%	-$90	﹤0.01%	3309
2021 Q4	$17K	Buy	593 +17	+3%	+$860	﹤0.01%	3305
2021 Q3	$56K	Buy	576 +1	+0.2%	+$108	﹤0.01%	3231
2021 Q2	$75K	Buy	575 +285	+98%	+$41.1K	﹤0.01%	3241
2021 Q1	$52K	Buy	+290	New	+$56K	﹤0.01%	3212

Other funds holding ELTX

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MHC

Meyer Handelman Company Rye Brook, New York $3.53B AUM 30.49% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

MFA

Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return

MLL

Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

New York State Common Retirement Fund's ELTX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Elicio Therapeutics (ELTX) in Q2 2026: 14,200 shares worth $55.5K. The stake represents ﹤0.01% of the portfolio and ranks #2967 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in ELTX as recently as Q2 2022.

New York State Common Retirement Fund first reported a position in ELTX in Q1 2021 and has held it in 7 quarters since. The position peaked at $75K in Q2 2021. 11 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

New York State Common Retirement Fund held 14,200 shares of Elicio Therapeutics worth $55.5K as of Q2 2026.
Elicio Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
Elicio Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2967 holding.
New York State Common Retirement Fund first reported a position in Elicio Therapeutics in Q1 2021 and has held it in 7 quarters since.
New York State Common Retirement Fund's Elicio Therapeutics position peaked at $75K in Q2 2021.
11 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.